Company Filing History:
1 out of 869 
1 out of 21 
2 out of 832,718 Years Active: 2000-2004
Title: Nadia Soussi-Yanticostas: Innovator in Therapeutic Applications of KAL Protein
Introduction
Nadia Soussi-Yanticostas is a prominent inventor based in Paris, France. She has made significant contributions to the field of therapeutic treatments, particularly through her work with the KAL protein. With a total of 3 patents, her innovations focus on addressing critical medical challenges.
Latest Patents
Nadia's latest patents revolve around the use of the KAL protein in the treatment of retinal, renal, neuronal, and neural injuries. The KAL protein has been identified as the active agent in a therapeutic composition aimed at treating injuries to nerve tissue, including spinal cord tissue. This innovative approach also supports the treatment of renal grafts. Furthermore, the administration of KAL protein is effective in therapeutic treatments for renal injury, kidney transplantation, and renal surgery. The therapeutic agent can be administered either locally or intravenously, and it has shown potential in treating retinal disorders as well.
Career Highlights
Throughout her career, Nadia has worked with notable institutions, including the Institut Pasteur. Her research and inventions have positioned her as a key figure in the medical and scientific communities.
Collaborations
Nadia has collaborated with esteemed colleagues such as Christine Petit and Jean-Pierre Hardelin, further enhancing her contributions to the field.
Conclusion
Nadia Soussi-Yanticostas is a trailblazer in the application of KAL protein for therapeutic purposes. Her innovative patents and collaborations underscore her commitment to advancing medical science and improving patient outcomes.